Oliver Sartor speaks with Michael Schultz about advances in radiopharmaceuticals for cancer treatment. Dr. Schultz discusses the advantages of using alpha-particle emitters, particularly lead-212, for targeted cancer therapy. He explains the rationale behind choosing lead-212, including its short half-life and the ability to use lead-203 for imaging. Dr. Schultz addresses distribution challenges…
The American Hospital Association wants the Biden administration to take immediate actions to increase the supply of IV solutions for hospitals, such as invoking the…
Experts are puzzling over which interventions are saving lives. The evolving illicit supply itself may hold important clues.
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
Upcoming data from a mid-stage study of Amgen’s experimental weight-loss drug MariTide will shed light on how well it might measure up against the popular…
IVC filters, implants that prevent blood clots, aren’t meant to be permanent — but doctors often forge to retrieve them.
Trump’s #tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
The film, “The M Factor: Shredding the Silence on Menopause,” is accredited for physicians
This collection emphasizes how our understanding of cell death is constantly evolving and underlines the importance of molecular pathways in the context of development and…
The review highlights three operational phases: gaseous and dense phases for pipeline transport and liquid for non-pipeline transport of CO2. It emphasizes project-specific impurity limits…
On Wednesday, November 13, 2024, the Johns Hopkins Center for Health Equity welcomed Maya Venkataramani MD, MPH for the November Health Equity Jam Session. D…
